Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.33−0.39 (-2.65%)
Close on Nov 18, 2026Market cap $779.08MP/E –Yield –
Beta Bionics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Beta Bionics's operating income for the twelve months ending Sep 30, 2026 was -$92.58M. For fiscal 2025 it was -$71.68M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$71.68M | – |
| FY2024 | Dec 31, 2024 | -$45.25M | – |
| FY2023 | Dec 31, 2023 | -$35.85M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$26.61M | – |
| Q2 FY2026 | Jun 30, 2026 | -$25.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$24.27M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.12M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.64M | – |
| Q4 FY2024 | Dec 31, 2024 | -$13.04M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.98M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.45M | – |
See a number that looks wrong?